Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Assets (2021 - 2025)

Rani Therapeutics Holdings has reported Return on Assets over the past 5 years, most recently at 1.17% for Q4 2025.

  • Quarterly results put Return on Assets at 1.17% for Q4 2025, up 24.0% from a year ago — trailing twelve months through Dec 2025 was 1.17% (up 24.0% YoY), and the annual figure for FY2025 was 0.85%, up 35.0%.
  • Return on Assets for Q4 2025 was 1.17% at Rani Therapeutics Holdings, up from 3.52% in the prior quarter.
  • Over the last five years, Return on Assets for RANI hit a ceiling of 0.41% in Q4 2021 and a floor of 3.52% in Q3 2025.
  • Median Return on Assets over the past 5 years was 0.99% (2023), compared with a mean of 1.15%.
  • Peak annual rise in Return on Assets hit 24bps in 2025, while the deepest fall reached -226bps in 2025.
  • Rani Therapeutics Holdings' Return on Assets stood at 0.41% in 2021, then tumbled by -44bps to 0.59% in 2022, then crashed by -80bps to 1.06% in 2023, then plummeted by -33bps to 1.41% in 2024, then increased by 17bps to 1.17% in 2025.
  • The last three reported values for Return on Assets were 1.17% (Q4 2025), 3.52% (Q3 2025), and 2.55% (Q2 2025) per Business Quant data.